Hong Kong, 20 December 2019 — The board of directors (the “Board”) of CSPC Pharmaceutical Group Limited (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that Conjupri®…Original Article
FDA Approves Conjupri (levamlodipine maleate) for the Treatment of Hypertension
